CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE I TRIAL OF CLIC-2201 FOR THE TREATMENT OF RELAPSED/REFRACTORY B CELL MALIGNANCIES

Intervention/treatment:
CLIC-2201 / FLUDARABINE PHOSPHATE / CYCLOPHOSPHAMIDE
Medical condition:
B-CELL MALIGNANCIES
Protocol code:
CLIC-02
Control number:
287599
Status:
Recruiting
Approved:
July 18, 2024
Trial phase:
Phase 1
For more information:
ClinicalTrials.gov - NCT06208735
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
1 Year and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Kevin Hay, MD
Role
CONTACT
Phone:
(403) 210-6191
Name
Narsis Afghari, MSc
Role
CONTACT
Phone:
(604) 675-4100
Extension 203838
Sponsor
BC CANCER, PART OF THE PROVINCIAL HEALTH SERVICES AUTHORITY

Locations

Alberta

Alberta Children's Hospital
Calgary, Alberta, T3B 6A8
RECRUITING
Name
Sherry Qian
Role
CONTACT
Name
Victor Lewis, MD
Role
PRINCIPAL_INVESTIGATOR
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2
RECRUITING
Name
Oluwaponmile Odukoya
Role
CONTACT
Name
Robert Puckrin, MD
Role
PRINCIPAL_INVESTIGATOR

British Columbia

BC Children's Hospital
Vancouver, British Columbia, V5Z 1M9
RECRUITING
Name
Nima Molavi
Role
CONTACT
Name
Amanda Li, MD
Role
PRINCIPAL_INVESTIGATOR
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9
RECRUITING
Name
Madeleine Cannings
Role
CONTACT
Name
Hannah Cherniawsky, MD
Role
PRINCIPAL_INVESTIGATOR

Ontario

Princess Margaret Cancer Centre
Toronto, Ontario
RECRUITING
Name
Aidan Shair
Role
CONTACT
Name
John Kuruvilla, MD
Role
PRINCIPAL_INVESTIGATOR
The Hospital for Sick Children
Toronto, Ontario
RECRUITING
Name
Erilda Kapllani
Role
CONTACT
Name
Joerg Krueger, MD
Role
PRINCIPAL_INVESTIGATOR
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6
RECRUITING
Name
Vanessa Lopez
Role
CONTACT
Name
Natasha Kekre, MD
Role
PRINCIPAL_INVESTIGATOR
Name
Harold Atkins, MD
Role
SUB_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources